KROS - Keros Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KROS is currently covered by 8 analysts with an average price target of $33.33. This is a potential upside of $14.13 (73.59%) from yesterday's end of day stock price of $19.2.

Keros Therapeutics 's activity chart (see below) currently has 62 price targets and 66 ratings on display. The stock rating distribution of KROS is 68.75% BUY and 31.25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 39.48% with an average time for these price targets to be met of 54.92 days.

Highest price target for KROS is $27, Lowest price target is $15, average price target is $22.86.

Most recent stock forecast was given by ANDREAS ARGYRIDES from OPPENHEIMER on 12-Nov-2025. First documented stock forecast 04-May-2020.

Currently out of the existing stock ratings of KROS, 11 are a BUY (68.75%), 5 are a HOLD (31.25%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 31-Jul-2023

$27

$7.8 (40.63%)

$23

1 months 30 days ago
(12-Nov-2025)

0/8 (0%)

$9.53 (54.55%)

Hold

Since 17-Jan-2025

$16

$-3.2 (-16.67%)

$15

2 months 5 days ago
(06-Nov-2025)

3/4 (75%)

$-0.17 (-1.05%)

70

Buy

Since 08-Dec-2023

$26

$6.8 (35.42%)

$26

2 months 22 days ago
(20-Oct-2025)

1/4 (25%)

$10.81 (71.17%)

74

Buy

Since 26-Jul-2023

$26

$6.8 (35.42%)

$41

7 months 30 days ago
(12-May-2025)

1/6 (16.67%)

$12.26 (89.23%)

215

Buy

Since 04-May-2020

$25

$5.8 (30.21%)

$40

8 months 3 days ago
(08-May-2025)

1/14 (7.14%)

$10.98 (78.32%)

113

Show more analysts

Please expand the browser size to see the chart

What is KROS (Keros Therapeutics ) average time for price targets to be met?

On average it took 54.92 days on average for the stock forecasts to be realized with a an average price target met ratio 39.48

Which analyst has the current highest performing score on KROS (Keros Therapeutics ) with a proven track record?

DANIELLE BRILL

Which analyst has the most public recommendations on KROS (Keros Therapeutics )?

Danielle Brill works at TRUIST and has 7 price targets and 7 ratings on KROS

Which analyst is the currently most bullish on KROS (Keros Therapeutics )?

Tom Smith with highest potential upside - $60.8

Which analyst is the currently most reserved on KROS (Keros Therapeutics )?

Joseph Catanzaro with lowest potential downside - -$4.2

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?